We previously reported that a single immunization of BALB/c mice (8 weeks old) with our adenovirus-based COVID-19 vaccine (Ad5.S1) via either i.n. or s.c. delivery elicited robust S1-specific humoral and cellular immune responses in mice. This evidence concerns the gene PSMD1 and COVID-19.